** Exane BNP Paribas ups Eurofins EUFI.PA by two notches, to "outperform" from "underperform", noting a shift from network building to 'harvesting (...) growth and cash'
** The broker says the French medical research group is "entering the sweet spot of higher growth" as governance issues recede, with margins expected to climb above 24%
** Reflecting higher estimates and confidence in returns, BNP raises PT by 46% to EUR 75
** The broker ups its 2025-2027 earnings forecasts by 5% on average
** It adds that the peak in capex has been crested and FCF generation, a historical concern for investors, is on an improving path
(Reporting by Jakob Van Calster)
((jakob.vancalster@thomsonreuters.com))